Meckler Jeffrey A 4
4 · Indaptus Therapeutics, Inc. · Filed Jul 29, 2025
Insider Transaction Report
Form 4
Meckler Jeffrey A
DirectorCo-Chief Executive Officer
Transactions
- Award
Common Stock
2025-07-27$8.30/sh+6,068$50,379→ 13,312 total - Award
Common Stock Warrants
2025-07-27$8.30/sh+12,136$100,758→ 16,688 totalExercise: $8.30From: 2025-07-27Exp: 2030-07-27→ Common Stock (12,136 underlying)
Footnotes (1)
- [F1]The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025.